Chemoendocrine therapy shows a greater negative association with patient-reported cognitive decline than endocrine therapy ...
The Canadian Press on MSN
Companies can make generic Ozempic as of next week in Canada, but don’t expect to get it soon
Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug Ozempic as of next week, ...
“Gedatolisib plus Faslodex, with or without Ibrance, represents a potential new standard of care for patients with hormone ...
Piqray plus Faslodex significantly improved PFS in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast ...
Wellbeing Magazine on MSN
Best supplements to balance hormones: Your pick for 2026
The issues concerning the hormone balance have a great impact on the general well-being, the level of energy, the mood ...
Hormone therapy can affect collagen, hydration, and breakouts during menopause. Dermatologists explain the real skin benefits ...
Maintaining CDK4/6 inhibition constrains drug‑resistant breast tumors by delaying cell‑cycle entry, and adding CDK2 inhibition further deepens control to guide post‑progression therapy.
Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.
Researchers have investigated the role that estrogen plays in signaling more gut pain, and it isn't working alone.
With the black box warning a thing of the past, interest in these once-controversial medications is growing, say experts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback